Login to Your Account



Financings Roundup

ChemoCentryx Looks to IPO To Groom Drug Candidates

By Mari Serebrov


Tuesday, October 18, 2011
With a stable full of promising contenders, ChemoCentryx Inc. hopes to raise $69 million in an initial public offering (IPO) to keep its drug candidates on the clinical development track.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription